Biomerica Inc Expands Commercial Presence in Canada with Strategic Partnerships

Published: 2026-04-14 16:53:46 ET BMRA

Published on 04/14/2026 at 04:53 pm EDT

Biomerica, Inc. announced the commercial launch of its inFoods platform in Canada through two strategic partnerships: Phoenix Airmid Biomedical, which will serve as the exclusive Canadian distribution partner, and CanAlt Health Labs, which will provide certified laboratory processing services to support inFoods IBS testing across the country. This launch represents a significant milestone in Biomerica?s international commercialization strategy, establishing the Company?s first commercial presence in the Canadian market and expanding patient access to its clinically validated, non-pharmaceutical approach to managing gastrointestinal symptoms. Canada represents a substantial and underserved commercial opportunity for the inFoods IBS platform. According to the Canadian Digestive Health Foundation and peer-reviewed research, IBS is a widespread and economically significant condition across the country.

Under the terms of the agreements: Phoenix Airmid Biomedical will manage distribution, physician outreach, and commercial sales of the inFoods IBS platform across Canada, leveraging its established relationships within the Canadian healthcare system. CanAlt Health Labs, a Canadian clinical laboratory, will serve as the certified lab processing partner, responsible for conducting inFoods IBS testing and delivering results to physicians, naturopathic doctors, and their patients nationwide.